During the past decade, St. Vincentius - Kliniken conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 12 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincentius - Kliniken" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "AGO Study Group" with 5 trials sponsored, "AGO Research GmbH" with 4 trials sponsored, "German CLL Study Group" with 2 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincentius - Kliniken" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator, "German Breast Group" with 4 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator and "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincentius - Kliniken" are "Ovarian Cancer" (9 trials), "Breast Cancer" (7 trials), "Fallopian Tube Cancer" (7 trials), "Leukemia" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "St. Vincentius - Kliniken" in a lesser frequency.

Most popular intervention types in "St. Vincentius - Kliniken" are "Drug" (54 trials), "Biological" (6 trials), "Radiation" (5 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (9 trials), "Bevacizumab" (7 trials), "Gemcitabine" (6 trials), "Paclitaxel" (5 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincentius - Kliniken" are 32 trials for "All" genders and 24 trials for "Female" genders.

Currently, there are NaN active trials in "St. Vincentius - Kliniken". undefined are not yet recruiting, 9 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in St. Vincentius - Kliniken, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincentius - Kliniken, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

St. Vincentius - Kliniken has several departments that took part in Clinical trials: "St. Vincentius Kliniken Karlsruhe; Abteilung Hämatologie / Onkologie" - 3 trials